2 February 2022
PharmaBoardoom points out VIVEbiotech as one of the ten Spanish Biotechs to watch in 2022
PharmaBoardroom, a leading British media specialized in the health sector, has published an article in...
GMP CDMO focused on different stages of the process.
We work exclusively in lentivirus, offering comprehensive services.
Technical adaptation and timely slot availability for each project.
Compliance with EMA and FDA regulatory requirements.
in the US, Europe, Asia and Australia
in reactor since 2020
since 2018
exclusively to lentivirus production
combining young talent and experience
We are a Contract Development and Manufacturing Organization (CDMO) with over 35 biotech companies worldwide that have placed their trust in us.
Read moreVIVEbiotech is one of the only companies in the world specialized exclusively in lentiviral vectors. One of the things that sets us apart is our expertise not only in production but also virology, backed by a team of professionals with more than 30 years of experience.
Read more2 February 2022
PharmaBoardroom, a leading British media specialized in the health sector, has published an article in...
2 May 2022
The CEO of VIVEbiotech, Dr. Gurutz Linazasoro, is part of the prestigious The Medicine Maker...